As more UK studies are done, we may learn more about how these peptides work
The second phase will focus on its long-term effectiveness in helping these children manage their weight, with final results expected in 2030
The American Association of Clinical Endocrinology (AACE) 2022 obesity guidelines, available at aace.com, explicitly list GLP-1 receptor agonists as second-line pharmacotherapy for patients with insulin resistance or metabolic obesity
Circ Cardiovasc Genet 7 , 321331 (2014)
Being male (paradoxically, except for androgenetic alopecia), starting at lower retatrutide doses with slow titration, maintaining excellent nutrition throughout, having no history of stress-related shedding, and having robust baseline micronutrient levels all lower your likelihood of significant hair loss